Skip to main content
MedPathMedPath Home
Clinical Trials/KCT0006745
KCT0006745
Recruiting
未知

Pilot study to evaluate the efficacy and safety of MegaNuovo in Pressure sore patients : single center, comparative, investigator-initiated pilot study

Yonsei University, Wonju Severance Christian Hospital0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiseases of the skin and subcutaneous tissue

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the skin and subcutaneous tissue
Sponsor
Yonsei University, Wonju Severance Christian Hospital
Enrollment
30
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Yonsei University, Wonju Severance Christian Hospital

Eligibility Criteria

Inclusion Criteria

  • •? Patients aged 19 to less than 90 years of age
  • •? Patients with stage 2\~4 pressure ulcers
  • •? Patients who have fully explained the purpose and contents of the test before taking the test and voluntarily signed the written consent (a legal representative can represent him if necessary)
  • •? Patients who can follow\-up during the test period

Exclusion Criteria

  • •? HbA1c\=12%
  • •? Patients with evidence of active infection including osteomyelitis or cellulitis
  • •? Patients who want surgical treatment
  • •? Pregnant and lactating women (urine hCG test)
  • •? Patients with psychiatric problems
  • •? Patients with infectious diseases, systemic autoimmune diseases (rheumatic diseases, etc.), blood clotting disorders (diagnosed by medical staff through questionnaire and physical examination)
  • •? In case it is judged difficult to conduct clinical trials by the principal investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19)COVID-19 infection is being spread around the world with more than 400.000 cases. The spred of the disease is being a world health problem.Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2020-001194-69-ESFélix Gutiérrez Rodero200
Completed
Not Applicable
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucoma
ISRCTN23263504Transcend Medical, Inc.™ (USA)20
Completed
Not Applicable
Transcend CyPass glaucoma implant and cataract surgery in open angle glaucoma patients
ISRCTN86839890Transcend Medical, Inc.™ (USA)20
Active, not recruiting
Not Applicable
A pilot study to assess the efficacy and safety of LCQ908 alone and in combination with fenofibrate or Lovaza® in patients with severe hypertriglyceridemiaon Familial Chylomicronemia Syndrome (Non-FCS)MedDRA version: 14.1Level: LLTClassification code 10020870Term: HypertriglyceridemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]Non Familial Chylomicronemia Syndrome (Non-FCS)
EUCTR2012-000872-40-CZovartis Pharma Services AG60
Completed
Phase 3
A pilot study to assess the efficacy and safety of Heliox inhalation therapy for resuscitation to preterm infants.preterm infants
JPRN-UMIN000015061agano Children's Hospital10